TREA

88177424 - INNOVENT

Follow

Information

  • Trademark
  • 88177424
  • Serial Number
    88177424
  • Registration Number
    6236173
  • Filing Date
    November 01, 2018
    6 years ago
  • Registration Date
    January 05, 2021
    3 years ago
  • Transaction Date
    January 05, 2021
    3 years ago
  • Status Date
    January 05, 2021
    3 years ago
  • Published for Opposition Date
    October 20, 2020
    4 years ago
  • Location Date
    January 05, 2021
    3 years ago
  • Status Code
    700
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    PATE, TARA J
  • Attorney Docket Number
    235599438760
    Attorney Name
    Anessa Owen Kramer
    Law Office Assigned Location Code
    S10
  • Owners
Information
Mark Drawing Code
3000
Mark Identification
INNOVENT
Case File Statements
  • CC0000: Color is not claimed as a feature of the mark.
  • D10000: THE NON-LATIN CHARACTERS THAT TRANSLITERATE TO "SHENGWUZHIYAO"
  • DM0000: The mark consists of the word "INNOVENT"; the "O" in "INNOVENT" is comprised of two symmetrical arcs, with Chinese characters beneath the word "INNOVENT".
  • GS0051: Medicines for human purposes, used for treating tumor, ophthalmology diseases, cardiovascular diseases, immune diseases, metabolic diseases, blood diseases, diabetes, endocrine system diseases, reproductive system diseases, respiratory system diseases, central and peripheral nervous system diseases, cancer, and antivirals; pharmaceutical preparations, used for treating tumor, ophthalmology diseases, cardiovascular diseases, immune diseases, metabolic diseases, blood diseases, diabetes, endocrine system diseases, reproductive system diseases, respiratory system diseases, central and peripheral nervous system diseases, cancer, and antivirals; drugs in the nature of pharmaceutical preparations for medical purposes, used for treating tumor, ophthalmology diseases, cardiovascular diseases, immune diseases, metabolic diseases, blood diseases, diabetes, endocrine system diseases, reproductive system diseases, respiratory system diseases, central and peripheral nervous system diseases, cancer, and antivirals; chemico-pharmaceutical preparations, used for treating tumor, ophthalmology diseases, cardiovascular diseases, immune diseases, metabolic diseases, blood diseases, diabetes, endocrine system diseases, reproductive system diseases, respiratory system diseases, central and peripheral nervous system diseases, cancer, and antivirals; chemical preparations for medical purposes, used for treating tumor, ophthalmology diseases, cardiovascular diseases, immune diseases, metabolic diseases, blood diseases, diabetes, endocrine system diseases, reproductive system diseases, respiratory system diseases, central and peripheral nervous system diseases, cancer, and antivirals; injectable preparations for medical purposes, used for treating tumor, ophthalmology diseases, cardiovascular diseases, immune diseases, metabolic diseases, blood diseases, diabetes, endocrine system diseases, reproductive system diseases, respiratory system diseases, central and peripheral nervous system diseases, cancer, and antivirals; biological preparations for medical purposes, used for treating tumor, ophthalmology diseases, cardiovascular diseases, immune diseases, metabolic diseases, blood diseases, diabetes, endocrine system diseases, reproductive system diseases, respiratory system diseases, central and peripheral nervous system diseases, cancer, and antivirals; vaccines; diagnostic preparations for medical purposes; dietetic foods adapted for medical use; biological tissue cultures for medical purposes; nutraceutical preparations for use as a dietary supplement for therapeutic or medical purposes
  • TLIT00: The non-Latin characters in the mark transliterate to "XIN DA SHENG WU ZHI YAO" and this means "integrity", "action", "bio-pharmaceuticals" in English.
Case File Event Statements
  • 1/5/2021 - 3 years ago
    31 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 10/20/2020 - 4 years ago
    30 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 10/20/2020 - 4 years ago
    29 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 9/30/2020 - 4 years ago
    28 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 9/17/2020 - 4 years ago
    27 - 1(B) BASIS DELETED; NEW BASIS REQUESTED Type: ADBS
  • 9/17/2020 - 4 years ago
    26 - NOTICE OF ALLOWANCE CANCELLED Type: IUCN
  • 9/11/2020 - 4 years ago
    25 - ATTORNEY REVIEW/DECISION ON AMENDMENT REQUIRED Type: ATRQ
  • 9/11/2020 - 4 years ago
    24 - PETITION TO DIRECTOR - CHANGE BASIS - GRANTED Type: PCBG
  • 9/9/2020 - 4 years ago
    23 - ASSIGNED TO PETITION STAFF Type: APET
  • 7/24/2020 - 4 years ago
    22 - TEAS PETITION TO AMEND BASIS RECEIVED Type: TPAD
  • 6/16/2020 - 4 years ago
    21 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM
  • 4/21/2020 - 4 years ago
    20 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 4/21/2020 - 4 years ago
    19 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 4/1/2020 - 4 years ago
    18 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 3/19/2020 - 4 years ago
    17 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 3/13/2020 - 4 years ago
    16 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 3/12/2020 - 4 years ago
    15 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 3/12/2020 - 4 years ago
    14 - TEAS REQUEST FOR RECONSIDERATION RECEIVED Type: ERFR
  • 2/26/2020 - 4 years ago
    13 - NOTIFICATION OF FINAL REFUSAL EMAILED Type: GNFN
  • 2/26/2020 - 4 years ago
    12 - FINAL REFUSAL E-MAILED Type: GNFR
  • 2/26/2020 - 4 years ago
    11 - FINAL REFUSAL WRITTEN Type: CNFR
  • 8/24/2019 - 5 years ago
    10 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 8/23/2019 - 5 years ago
    9 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 8/23/2019 - 5 years ago
    8 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 3/11/2019 - 5 years ago
    7 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 3/11/2019 - 5 years ago
    6 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 3/11/2019 - 5 years ago
    5 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 2/7/2019 - 5 years ago
    4 - ASSIGNED TO EXAMINER Type: DOCK
  • 11/17/2018 - 6 years ago
    3 - NOTICE OF DESIGN SEARCH CODE E-MAILED Type: MDSC
  • 11/16/2018 - 6 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM Type: NWOS
  • 11/5/2018 - 6 years ago
    1 - NEW APPLICATION ENTERED IN TRAM Type: NWAP